Search results

Order by most recent / most popular / relevance

Results: 1-4 of 4

Universities abroad experiment with no-fee licensing to drive biotech partnerships

Shook Hardy & Bacon LLP
-
Australia, Canada, European Union, United Kingdom, USA
-
May 16 2013

Universities in Australia, Canada, Europe, and the United Kingdom have reportedly embraced a 2010 Glasgow University initiative under which companies

The patentability of stem cells: WARF's success and failure on opposite sides of the Atlantic

Shepherd & Wedderburn LLP
-
European Union, United Kingdom, USA
-
March 31 2008

The Wisconsin Alumni Research Foundation (WARF) has had three of its patents in relation to stem cells (and in particular, methods of isolation) upheld by the United States Patent and Trademark Office (USPTO

EU, US regulators ease process for orphan drugs

Gowling Lafleur Henderson LLP
-
European Union, USA
-
December 6 2007

In an effort to encourage development of drug treatments for rare diseases, the European Commission, the European Medicines Agency and the U.S. Food and Drug Administration announced steps to streamline the application process for orphan drugs

Patent misuse in the pharmaceutical industry: developments in US & EU

Wragge & Co LLP
-
European Union, USA
-
October 31 2007

The pharmaceutical industry has been scrutinised closely by competition authorities and courts in the US and Europe

Search results

Universities abroad experiment with no-fee licensing to drive biotech partnerships

The patentability of stem cells: WARF's success and failure on opposite sides of the Atlantic

EU, US regulators ease process for orphan drugs

Patent misuse in the pharmaceutical industry: developments in US & EU

Current Search

Suggested Facets

Author

Firm Name

Jurisdiction

Workarea